TAZOMAC PS INJECTION 1.125GM

TAZOMAC PS Injection 1.125 GM – Product Overview

TAZOMAC PS Injection 1.125 GM is a combination antibiotic designed to combat a wide range of bacterial infections. It contains Piperacillin, a penicillin-class antibiotic, and Tazobactam, a beta-lactamase inhibitor that enhances the efficacy of Piperacillin by protecting it from bacterial resistance mechanisms. This potent formulation is especially effective against infections acquired in hospitals and those associated with ventilator use. Administered intravenously by trained healthcare professionals, TAZOMAC PS Injection targets the bacteria responsible for severe infections while minimizing the risk of complications. Completing the full course as prescribed is essential to prevent recurrence and bacterial resistance.

Uses

TAZOMAC PS Injection 1.125 GM is prescribed for a variety of serious bacterial infections, including:

• Respiratory infections – hospital-acquired and ventilator-associated pneumonia

• Urinary tract infections – kidney and bladder infections

• Intra-abdominal infections – including peritonitis and post-surgical infections

• Skin and soft tissue infections – diabetic foot infections, surgical wounds, and cellulitis

• Gynecological infections – pelvic inflammatory disease, endometritis, and uterine infections

Benefits

• Broad-spectrum antibacterial action – targets both gram-positive and gram-negative bacteria

• Enhanced efficacy – Tazobactam prevents bacterial enzymes from inactivating Piperacillin

• Rapid infection control – helps patients recover quickly when administered appropriately

• Versatile application – effective across multiple infection sites including lungs, urinary tract, skin, and abdomen

How It Works

• Piperacillin: Kills bacteria by binding to penicillin-binding proteins in the bacterial cell wall, preventing its synthesis and causing bacterial cell death

• Tazobactam: Inhibits beta-lactamase enzymes produced by resistant bacteria, protecting Piperacillin and maintaining its antibacterial action

Administration

TAZOMAC PS Injection 1.125 GM is administered under medical supervision via intravenous infusion. Self-administration is not recommended. Dosage is determined by the type and severity of infection and patient-specific factors such as kidney and liver function. The first dose is typically administered by a healthcare professional, and they may guide patients on subsequent doses if self-administration is required.

Safety and Precautions

• Allergies: Disclose any penicillin or antibiotic allergies to your doctor

• Kidney or liver conditions: Dose adjustment may be needed

• Pregnancy and breastfeeding: Safe when prescribed and monitored by a doctor

• Vaccinations: Avoid live bacterial vaccines while on treatment

• Elderly patients: Usually safe; dosage adjustment may be necessary in case of renal impairment

• Children: Safety and effectiveness in infants below two months are not established

Possible Side Effects

Common side effects are mild and temporary:

• Nausea and vomiting

• Diarrhea or constipation

• Indigestion and stomach discomfort

• Headache and sleep disturbances

• Injection site reactions such as pain or swelling
  Seek immediate medical attention for severe allergic reactions or persistent gastrointestinal symptoms.

Drug Interactions

• Severe interactions: Piperacillin with Vancomycin or Heparin may require careful monitoring

• Food interactions: Avoid grapefruit and grapefruit juice as it may reduce antibiotic effectiveness

• Lifestyle advice: Maintain hydration, balanced diet, regular exercise, and hygiene to support recovery

Storage

Store in a cool, dry place away from sunlight, preferably between 10ºC and 25ºC. Keep out of reach of children. Avoid using the injection if it appears discolored, cloudy, or contains particles.

Overdose

Overdose is rare due to supervised administration but may result in nausea, vomiting, or diarrhea. Contact a doctor immediately if overdose is suspected.

Medicinal Benefits

TAZOMAC PS Injection 1.125 GM effectively treats bacterial infections of the lungs, urinary tract, abdomen, skin, and uterus. The combination of Piperacillin and Tazobactam ensures broad-spectrum antibacterial activity while preventing bacterial resistance.

Product Variants & Keywords

TAZOMAC PS Injection 1.125 GM, TAZOMAC PS IV Injection, Piperacillin Tazobactam Injection, TAZOMAC PS Antibiotic Injection, TAZOMAC PS 1.125g Injection